IP Library Granted Patent US 7,355,043
Granted Patent B2
US 7,355,043 · App. 11/011,352 · Granted Apr 8, 2008

Preparation of purines

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,355,043
App. No.
11/011,352
Granted
Apr 8, 2008
Kind
B2
Abstract

A process for the preparation of a compound of formula (A) wherein: X is hydrogen or hydroxy, chloro, C 1-6 alkoxy or pheny C 1-6 alkoxy; and R a and R b are hydrogen, or acyl or phosphate derivatives thereof, which process comprises: (i) the preparation of a compound of formula (I) wherein R 1 is C 1-6 alkyl, or phenyl C 1-6 alkyl in which the phenyl group is optionally substituted; R 2 is hydrogen, hydroxy, chlorine, C 1-6 alkoxy, phenyl C 1-6 alkoxy or amino; and R 3 is halogen, C 1-6 alkylthio, C 1-6 alkylsulphonyl, azido, an amino group or a protected amino group, which preparation comprises the reaction of a compound of formula (II) wherein R 2 and R 3 are as defined for formula (I) with a compound of formula (V) wherein L is a leaving group and R 1 is as defined for formula (I), to give a compound of formula (VI), and thereafter converting the intermediate compound of formula (VI) to a compound of formula (I) via decarboxylation, and as necessary or desired, interconverting variables R 1 , R 2 and R 3 to further values of R 1 , R 2 and R 3 ; (ii) the conversion of the resulting compound of formula (I) to a compound of formula (A) by converting variable R 3 , when other than amino, to amino, reducing the ester groups CO 2 R 1 to CH 2 OH and optionally forming acyl or phosphate derivates thereof, and as necessary or desired converting variable R 2 in the compound of formula (I) to variable X in the compound of formula (A); characterized in that R 2 is chloro in formula (I)

Claims (17)

1. A process for the preparation of a compound of formula (A):

wherein:

X is hydrogen or hydroxy; and R a and R b are hydrogen or acetyl, which process comprises:

(i) the preparation of a compound of formula (I):

wherein R 1 is C 1-6 alkyl, or phenyl C 1-6 alkyl in which the phenyl group is optionally substituted; and R 3 is an amino group or a protected amino group, which preparation comprises the reaction of a compound of formula (II):

wherein R 3 is as defined above for formula (I), with a compound of formula (V):

wherein L is a leaving group and R 1 is as defined for formula (I), to give a compound of formula (VI):

and thereafter converting the intermediate compound of formula (VI) to a compound of formula (I) via decarboxylation; and

(ii) conversion of the resulting compound of formula (I) to a compound of formula (A) by:

a) removal, if necessary, of the amino protecting group;

b) reducing the ester groups CO 2 R 1 to CH 2 OH groups, and, if necessary, acetylating to form the corresponding CH 2 Oac groups; and

c) dechlorinating via a hydrogenolysis reaction to yield a compound of Formula (A) in which X is hydrogen; or dechlorinating via a hydrolysis reaction to yield a compound of Formula (A) in which X is hydroxy.

2. A process according to claim 1 for the preparation of 9-(4-acetoxy-3-acetoxymethylbut-l-yl)-2-aminopurine (famciclovir).

3. A processing according to claim 1 for the preparation of 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine (penciclovir).

4. A process according to claim 1 wherein, in the compound of Formula (V), R 1 is C 1-6 alkyl and L is halogen.

5. A process according to claim 4 , wherein L is bromo.

6. A process according to claim 1 , wherein R 1 is methyl or ethyl.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 1, 2011
From: NOVARTIS INTERANTIONAL PHARMACEUTICAL LTD.
To: NOVARTIS PHARMACEUTICALS CORPORATION
Reel/Frame 026535/0503 →